B. Schaefer

发表

Molecular and functional characterization of the four-transmembrane molecule l6 in epidermal keratinocytes.

P. Friedl, M. Kramer, R. Wallich, 2001, Experimental cell research.

Reconstructing the urinary bladder

C. Lorenz, B. Schaefer, 1999, Nature Biotechnology.

Cell surface-bound urokinase-type plasminogen activator facilitates infiltration of freshly isolated granulocytes into fibrin matrix.

H. Spring, M. Kramer, R. Todd, 1995, Immunobiology.

Human VAT-1: a calcium-regulated activation marker of human epithelial cells

J. Foekens, M. Timmermans, M. Kramer, 2003, Archives of Dermatological Research.

The membrane-associated protein pKe#192/MAP17 in human keratinocytes.

M. Kramer, R. Wallich, B. Schaefer, 2000, The Journal of investigative dermatology.

Expression of the helix-loop-helix protein ID1 in keratinocytes is upregulated by loss of cell-matrix contact.

M. Kramer, B. Schaefer, J. Koch, 2001, Experimental cell research.

Immunohistochemical and molecular characterization of cultured keratinocytes after dispase‐mediated detachment from the growth substratum

M. Kramer, R. Wallich, J. Reinartz, 2000, Experimental dermatology.

Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences.

M. Kramer, J. Reinartz, B. Schaefer, 1995, Biological chemistry Hoppe-Seyler.

Rapid normalization of epidermal integrin expression after allografting of human keratinocytes.

M. Kramer, B. Schaefer, H. Hohl, 1996, The Journal of investigative dermatology.

α2-Antiplasmin and plasminogen activator inhibitors in healing human skin wounds

M. Kramer, K. Maier, B. Schaefer, 1996, Archives of Dermatological Research.

Plasminogen activator inhibitor type‐2 in the lesional epidermis of lupus erythematosus

M. Kramer, B. Schaefer, M. Bechtel, 1996, The British journal of dermatology.

Plasminogen activator system in pemphigus vulgaris

M. Kramer, B. Schaefer, C. Jaeger, 1996, British Journal of Dermatology.

Plasminogen activation in bullous pemphigoid immunohistology reveals urokinase type plasminogen activator, its receptor and plasminogen activator inhibitor type-2 in lesional epidermis.

M. Kramer, B. Schaefer, C. Jaeger, 1996, Autoimmunity.

Upregulation of Cell-Surface-Associated Plasminogen Activation in Cultured Keratinocytes by Interleukin-1βand Tumor Necrosis Factor-α

M. Kramer, J. Reinartz, J. Rox, 1996 .

Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.

M. Kramer, J. Reinartz, J. Rox, 1996, Experimental cell research.

Dispase-mediated basal detachment of cultured keratinocytes induces urokinase-type plasminogen activator (uPA) and its receptor (uPA-R, CD87).

M. Kramer, J. Reinartz, B. Schaefer, 1996, Experimental cell research.

Autologous transplantation of urothelium into demucosalized gastrointestinal segments: evidence for epithelialization and differentiation of in vitro expanded and transplanted urothelial cells.

R. Moll, M. Kramer, W. Back, 1998, The Journal of urology.

Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.

M. Kramer, J. Reinartz, B. Schaefer, 1996, Experimental cell research.

Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.

N. Fusenig, M. Kramer, R. Todd, 1995, Experimental cell research.

Plasminogen activator inhibitor type‐2 in the lesional epidermis of lupus erythematosus

M. Kramer, B. Schaefer, M. Bechtel, 1996, The British journal of dermatology.